SMTI (Sanara MedTech Inc. Common Stock) Stock Analysis - Analyst Ratings

Sanara MedTech Inc. Common Stock (SMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, SMTI trades at $23.00 with a market cap of $200.60M and a P/E ratio of -5.28. SMTI moved +1.96% today. Year to date, SMTI is -2.38%; over the trailing twelve months it is -25.90%. Its 52-week range spans $16.05 to $39.08. Analyst consensus is buy with an average price target of $34.00. Rallies surfaces SMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SMTI?

2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $34.00.

SMTI Key Metrics

Key financial metrics for SMTI
MetricValue
Price$23.00
Market Cap$200.60M
P/E Ratio-5.28
EPS$-4.36
Dividend Yield0.00%
52-Week High$39.08
52-Week Low$16.05
Volume0
Avg Volume0
Revenue (TTM)$103.12M
Net Income$-37.57M
Gross Margin92.71%

SMTI Analyst Consensus

2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $34.00.

Latest SMTI News

Common questions about SMTI

What do analysts rate SMTI?
2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $34.00.
Does Rallies show SMTI price targets?
Yes. Rallies tracks SMTI analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SMTI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SMTI. It does not provide personalized investment advice.
SMTI

SMTI